Sort

Search

01/04/2024 SER recommendations on treatment of refractory Behc , et's syndrome
Morales, CM, Gil, JG, García, NB, Varillas, JLM, del Río, VC, Alvarado, PM, García, FJN, Espinosa, G, Fontecha, PDD, Rodríguez, MG, Arranz, JM, Gómez, ML, Hernández, FMF, Trujillo, MM, Sobrín, RD, Sánchez, JIM, Manzano, JM, Cuba, JS. SER recommendations on treatment of refractory Behc , et's syndrome. Reumatologia Clinica. 2024; 20(4)DOI:10.1016/j.reuma.2023.12.001. PMID:38614885. IF:(Q/D).
01/04/2024 Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV
Berenguer, J, Jarrín, I, Bellón, JM, Díez, C, Jiménez-Sousa, MA, López, JC, Pinto-Martínez, A, Moreno, S, Montes, ML, Iribarren, JA, Orviz, E, Portilla, J, Villarroya, F, Domingo, P, Resino, S. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. JOURNAL OF INFECTIOUS DISEASES. 2024; 230(2)DOI:10.1093/infdis/jiae168. PMID:38557859. IF:4.500(Q1/2D).
01/04/2024 Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation
Rofes, P, Dueñas, N, del Valle, J, Navarro, M, Balmaña, J, Ramón y Cajal, T, Tuset, N, Castillo, C, González, S, Brunet, J, Capellá, G, Lázaro, C, Pineda, M. Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation. Cancer Medicine. 2024; 13(7)DOI:10.1002/cam4.7041. PMID:38558366. IF:3.100(Q2/5D).
01/04/2024 Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
Orgueira, AM, Encinas, MMP, Varela, ND, Wang, YH, Mora, E, Diaz-Beya, M, Montoro, MJ, Marin, HP, Ortega, FR, Tormo, M, Jerez, A, Nomdedeu, J, Sanchez, CD, Arenillas, L, Carcel, P, Romero, MTC, Cirici, BX, Arango, ER, Barreto, RAD, Benlloch, L, Lin, CC, Tien, HF, Míguez, CP, Crucitti, D, Campelo, MD, Valcárcel, D. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. BRITISH JOURNAL OF HAEMATOLOGY. 2024; 204(4)DOI:10.1111/bjh.19341. PMID:38411250. IF:3.800(Q1/3D).
01/04/2024 RET Fusion Testing in Patients With NSCLC: The RETING Study
Conde, E, Hernandez, S, Carrillo, JLR, Martinez, R, Alonso, M, Curto, D, Jimenez, B, Caminoa, A, Benito, A, Garrido, P, Clave, S, Arriola, E, Esteban-Rodriguez, I, De Castro, J, Sansano, I, Felip, E, Rojo, F, Dómine, M, Abdulkader, I, Garcia-Gonzalez, J, Teixido, C, Reguart, N, Compañ, D, Insa, A, Mancheño, N, Palanca, S, Juan-Vidal, O, Baixeras, N, Nadal, E, Cebollero, M, Calles, A, Martin, P, Salas, C, Provencio, M, Aranda, I, Massuti, B, Lopez-Vilaro, L, Majem, M, Paz-Ares, L, Lopez-Rios, F. RET Fusion Testing in Patients With NSCLC: The RETING Study. Jto Clinical And Research Reports. 2024; 5(4)DOI:10.1016/j.jtocrr.2024.100653. PMID:38525319. IF:(Q/D).
01/04/2024 Recurrent Laryngeal Nerve Intraoperative Neuromonitoring Indications in Non-Thyroid and Non-Parathyroid Surgery
Brunet, A, Rovira, A, Quer, M, Sanabria, A, Guntinas-Lichius, O, Zafereo, M, Hartl, DM, Coca-Pelaz, A, Shaha, AR, Marie, JP, Vander Poorten, V, Piazza, C, Kowalski, LP, Randolph, GW, Shah, JP, Rinaldo, A, Simo, R. Recurrent Laryngeal Nerve Intraoperative Neuromonitoring Indications in Non-Thyroid and Non-Parathyroid Surgery. Journal of Clinical Medicine. 2024; 13(8)DOI:10.3390/jcm13082221. PMID:38673494. IF:2.900(Q1/2D).